Ecole de recherche translationnelle en neurosciences
Ouverture de l’appel à candidatures de l’école de recherche translationnelle en neurosciences Date limite : prolongation de l’appel à candidature : 30 novembre 2024 à 24h (heure de…
The aim of I2-D2 is to define individual trajectories of the NDD patients to early identify, in each child, the key factors responsible for the abnormal brain development, to develop predictive biomarkers, and ultimately individualized therapies.
The Excellence Center InovAND is designed to promote excellence in research and to foster the transfer of innovative discoveries to improve the understanding, prevention, diagnosis, treatment and care of people with neurodevelopmental disorders.
In 2019, the hospital hosted the creation of the FHU I2-D2 and the Autism and Neurodevelopmental Disorders Excellence Center InovAND, bringing together more than 30 clinical and scientific teams in a network designed to promote excellence in research.
Our aim is therefore to promote excellence and synergy among researchers and clinicians, within a single location – the Child Brain Institute – to accelerate the pace of scientific discoveries and, ultimately, to improve the cognitive and emotional development of children.
Ouverture de l’appel à candidatures de l’école de recherche translationnelle en neurosciences Date limite : prolongation de l’appel à candidature : 30 novembre 2024 à 24h (heure de…
Le TRT-5 CHV lance les inscriptions à son Forum d’échanges intitulé « Participer à la recherche : toute une science ! », organisé avec le soutien de l’ANRS-MIE et de la Direction Générale…
Webinaire d’information : Horizon Europe – Appels à projets collaboratifs européens 2025 Jeudi 3 octobre, de 12h00 à 13h30 Webinaire (100% en ligne) Intervenants : Aude RAIMBAULT, Paul…